These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27823885)

  • 1. Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies.
    Tonelli M; Espinoza S; Gainetdinov RR; Cichero E
    Eur J Med Chem; 2017 Feb; 127():781-792. PubMed ID: 27823885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists.
    Chiellini G; Nesi G; Digiacomo M; Malvasi R; Espinoza S; Sabatini M; Frascarelli S; Laurino A; Cichero E; Macchia M; Gainetdinov RR; Fossa P; Raimondi L; Zucchi R; Rapposelli S
    J Med Chem; 2015 Jun; 58(12):5096-107. PubMed ID: 26010728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design, chemical synthesis and biological evaluation of novel biguanides exploring species-specificity responsiveness of TAAR1 agonists.
    Guariento S; Tonelli M; Espinoza S; Gerasimov AS; Gainetdinov RR; Cichero E
    Eur J Med Chem; 2018 Feb; 146():171-184. PubMed ID: 29407948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Methods for the Discovery and Optimization of TAAR1 and TAAR5 Ligands.
    Scarano N; Espinoza S; Brullo C; Cichero E
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting species-specific trace amine-associated receptor 1 ligands: to date perspective of the rational drug design process.
    Cichero E; Tonelli M
    Future Med Chem; 2017 Sep; 9(13):1507-1527. PubMed ID: 28791911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hit-to-Lead Optimization of Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists with a Diphenylmethane-Scaffold: Design, Synthesis, and Biological Study.
    Chiellini G; Nesi G; Sestito S; Chiarugi S; Runfola M; Espinoza S; Sabatini M; Bellusci L; Laurino A; Cichero E; Gainetdinov RR; Fossa P; Raimondi L; Zucchi R; Rapposelli S
    J Med Chem; 2016 Nov; 59(21):9825-9836. PubMed ID: 27731647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a Novel Chemo-Type for TAAR1 Agonism via Molecular Modeling.
    Grossi G; Scarano N; Musumeci F; Tonelli M; Kanov E; Carbone A; Fossa P; Gainetdinov RR; Cichero E; Schenone S
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vivo pharmacology of Trace-Amine Associated Receptor 1.
    Lam VM; Espinoza S; Gerasimov AS; Gainetdinov RR; Salahpour A
    Eur J Pharmacol; 2015 Sep; 763(Pt B):136-42. PubMed ID: 26093041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking Studies.
    Francesconi V; Cichero E; Kanov EV; Laurini E; Pricl S; Gainetdinov RR; Tonelli M
    Pharmaceuticals (Basel); 2020 Nov; 13(11):. PubMed ID: 33202687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands.
    Hu LA; Zhou T; Ahn J; Wang S; Zhou J; Hu Y; Liu Q
    Biochem J; 2009 Oct; 424(1):39-45. PubMed ID: 19725810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the structure of the trace amine-associated receptor 2: Homology modelling studies exploring the binding mode of 3-iodothyronamine.
    Cichero E; Tonelli M
    Chem Biol Drug Des; 2017 May; 89(5):790-796. PubMed ID: 27863038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.
    Schwartz MD; Canales JJ; Zucchi R; Espinoza S; Sukhanov I; Gainetdinov RR
    Expert Opin Ther Targets; 2018 Jun; 22(6):513-526. PubMed ID: 29798691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further insights into the pharmacology of the human trace amine-associated receptors: discovery of novel ligands for TAAR1 by a virtual screening approach.
    Cichero E; Espinoza S; Franchini S; Guariento S; Brasili L; Gainetdinov RR; Fossa P
    Chem Biol Drug Des; 2014 Dec; 84(6):712-20. PubMed ID: 24894156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.
    Bräunig J; Dinter J; Höfig CS; Paisdzior S; Szczepek M; Scheerer P; Rosowski M; Mittag J; Kleinau G; Biebermann H
    Front Pharmacol; 2018; 9():222. PubMed ID: 29593543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging roles of human trace amines and human trace amine-associated receptors (hTAARs) in central nervous system.
    Khan MZ; Nawaz W
    Biomed Pharmacother; 2016 Oct; 83():439-449. PubMed ID: 27424325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trace amine associated receptor 1 (TAAR1) modulators: a patent review (2010-present).
    Tonelli M; Cichero E
    Expert Opin Ther Pat; 2020 Feb; 30(2):137-145. PubMed ID: 31865810
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyronamines and Analogues - The Route from Rediscovery to Translational Research on Thyronergic Amines.
    Chiellini G; Bellusci L; Sabatini M; Zucchi R
    Mol Cell Endocrinol; 2017 Dec; 458():149-155. PubMed ID: 28069535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand recognition and G-protein coupling of trace amine receptor TAAR1.
    Xu Z; Guo L; Yu J; Shen S; Wu C; Zhang W; Zhao C; Deng Y; Tian X; Feng Y; Hou H; Su L; Wang H; Guo S; Wang H; Wang K; Chen P; Zhao J; Zhang X; Yong X; Cheng L; Liu L; Yang S; Yang F; Wang X; Yu X; Xu Y; Sun JP; Yan W; Shao Z
    Nature; 2023 Dec; 624(7992):672-681. PubMed ID: 37935376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics.
    Revel FG; Moreau JL; Gainetdinov RR; Ferragud A; Velázquez-Sánchez C; Sotnikova TD; Morairty SR; Harmeier A; Groebke Zbinden K; Norcross RD; Bradaia A; Kilduff TS; Biemans B; Pouzet B; Caron MG; Canales JJ; Wallace TL; Wettstein JG; Hoener MC
    Biol Psychiatry; 2012 Dec; 72(11):934-42. PubMed ID: 22705041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Case for TAAR1 as a Modulator of Central Nervous System Function.
    Rutigliano G; Accorroni A; Zucchi R
    Front Pharmacol; 2017; 8():987. PubMed ID: 29375386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.